Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 mild to moderate meta-analysis

CORIMUNO-ANA-1, 2021
 
NCT04341584
RCTanakinracontrolCOVID-19 mild to moderatesome concern
59/57 inconclusive

    COVID-19 severe or critically meta-analysis

    Ana-COVID (Huet), 2020 OBSanakinracontrolCOVID-19 severe or criticallyserious
    52/44 suggested
    • suggested 78 % decrease in clinical deterioration,death or transfer to ICU but with a low degree of certainty due to high risk of bias

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).